Osseointegration International

12/05/2026

Osseointegration International heads to OT World Leipzig on 19–22 May for five accepted scientific sessions — covering complication and re-operation rates, rehabilitation outcomes under the OGAAP-3 protocol, a trans-scapular case report, and the past, present and future of bone-anchored prosthetics.

This year, we're focused on the lecture hall and direct meetings with surgeons, prosthetists, and clinical partners. No exhibition booth.

Learn more at osseointernational.com/ot-world?source=fb

03/03/2025

The OPL System: The World’s Most Widely Used Osseointegration Implant

The OPL System is the most widely used osseointegration implant globally, with over 1,500 implants utilised to date. Precision-engineered from high-strength titanium, it is available in over 150 sizes, ensuring a customised and secure fit for every patient.
Designed for both initial stability and long-term integration, the OPL System features a highly porous titanium coating that encourages bone in-growth, creating a seamless bone-implant connection. The dual cone adaptor, coated with BIOLOY, minimises soft tissue friction as it passes through the stoma, providing a smooth and stable interface between the implant and external prosthesis.

With multiple Connector options available, all compatible with standard prosthetic components, the OPL System offers a versatile and reliable solution for individuals seeking improved mobility and comfort through osseointegration.

For more information on the OPL System, contact [email protected].



Disclaimer: The content shared in this post is for informational purposes only and does not constitute medical advice. Individual results may vary. Always consult a qualified healthcare professional for personalised medical advice and treatment options.

24/01/2025

How do you prepare a short residuum for osseointegration?

A recent study [1] explored this very question, with reference to case of a 36-year-old farmer who had undergone bilateral above-knee amputation following an accident at work. His injuries meant that, while his right femur was suitable for a standard osseointegrated prosthetic limb (OPL) implant, his left femur – which measured only 9.2 cm — was too short.

The solution? Design and fabrication of a custom MILN to increase the length of the residual bone.

Lengthening was carried out at a rate of between 0.5mm and 1mm per day and, once complete, imaging confirmed good bone growth and consolidation – and an increase in the length of the residual limb of [LENGTH]. With the nail removed, and the patient doing well, the osseointegration could proceed!

This case demonstrates how important a patient-centred surgical approach is to achieving the best possible outcomes. The innovative combination of multiple reconstructive techniques means that even those with very complex needs can be treated successfully.

[1] Alttahir, M., Hoellwarth, J.S., Tetsworth, K. and Al Muderis, M. (2024). Freedom Nail Lengthening Followed by Press-Fit Osseointegration for the Transfemoral Amputee with Very Short Residual Bone, in Rozbruch, S.R. and Hamdy, R. (eds) Limb Lengthening and Reconstruction Surgery Case Atlas. Springer, Cham. https://doi.org/10.1007/978-3-319-02767-8_528-1

14/12/2024

A new case study by Prof. Munjed Al Muderis and colleagues demonstrates the viability, and benefits, of osseointegration for patients with a diagnosis of Peripheral Vascular Disease (PVD).

The patient in this case was 74 years old when they completed their left below-knee osseointegration surgery, and completed regular follow-ups over 10 years.

Originally wheelchair-bound, they demonstrated significant improvements in walking ability and quality of life following their surgery, with no demonstrable impact on their implant health or function as a result of their PVD.

Now 84 years old, the patient – and their implants – are still going strong.

If you have been diagnosed with PVD or another type of vascular insufficiency, and want more information about osseointegration, contact us at [email protected].



Disclaimer: The content shared in this post is for informational purposes only and does not constitute medical advice. Individual results may vary, and the experiences featured here do not guarantee specific outcomes. Always consult a qualified healthcare professional for personalised medical advice and treatment options.

Reference: Wongcharoenwatana, J., Alttahir, M., Arrieta, N. J., and Al Muderis, M. (2024). First peripheral vascular disease patient with 10-year follow-up after transtibial osseointegration. Journal of the American Academy of Orthopaedic Surgeons Global Research and Reviews, 8(11), Article e2400229. https://doi.org/10.5435/JAAOSGlobal-D-24-00229

13/12/2024

OPl Osseointegration Implant

07/12/2024

30/11/2024

We have been working hard this year to improve awareness of osseointegration among both patients and practitioners, worldwide.

As part of that drive, we’ve established partnerships with leading institutions and caregivers in Poland, Bahrain and Turkey, ensuring that more people than ever before have the opportunity to benefit from the same world-class osseointegration expertise and technology that has been available in Australia for more than a decade.

Some of our patients have reached out to us, worried that this work is a signal of change at Sydney. We want to reassure everybody that this isn’t the case. Sydney has been the headquarters of Osseointegration International and Osseointegration Group since their foundation, and we’re not planning on that changing. And we guarantee that our Australian patients will continue to receive the same world-leading care that they always have done.

If you are living with limb loss or considering amputation as a therapeutic option, and are interested in exploring your options for osseointegration at Sydney, either send us a message, or contact us at [email protected]

17/11/2024

Are you interested in undertaking an osseointegration fellowship with renowned orthopaedic surgeon Prof. Munjed Al Muderis and the expert team at Osseointegration International? For further details or to enquire, please contact us at [email protected].



Disclaimer: The content shared in this post is for informational purposes only and does not constitute medical advice. Individual results may vary, and the experiences featured here do not guarantee specific outcomes. Always consult a qualified healthcare professional for personalised medical advice and treatment options.